CS209853B2 - Method of making the semisynthetic cephalosporine - Google Patents
Method of making the semisynthetic cephalosporine Download PDFInfo
- Publication number
- CS209853B2 CS209853B2 CS748821A CS882174A CS209853B2 CS 209853 B2 CS209853 B2 CS 209853B2 CS 748821 A CS748821 A CS 748821A CS 882174 A CS882174 A CS 882174A CS 209853 B2 CS209853 B2 CS 209853B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- penicillin
- hydrolysis
- cephalosporin
- synthesis
- carried out
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title description 3
- HOKIDJSKDBPKTQ-UHFFFAOYSA-N 3-(acetyloxymethyl)-7-[(5-amino-5-carboxypentanoyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)C(NC(=O)CCCC(N)C(O)=O)C12 HOKIDJSKDBPKTQ-UHFFFAOYSA-N 0.000 title 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims abstract description 17
- 230000007062 hydrolysis Effects 0.000 claims abstract description 17
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 17
- 229930186147 Cephalosporin Natural products 0.000 claims abstract description 16
- 229940124587 cephalosporin Drugs 0.000 claims abstract description 16
- 150000001780 cephalosporins Chemical class 0.000 claims abstract description 16
- 241000588724 Escherichia coli Species 0.000 claims abstract description 13
- 108010073038 Penicillin Amidase Proteins 0.000 claims abstract description 9
- 150000001875 compounds Chemical class 0.000 claims abstract description 5
- 230000001580 bacterial effect Effects 0.000 claims abstract description 4
- 229940056360 penicillin g Drugs 0.000 claims abstract description 4
- 238000006243 chemical reaction Methods 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 19
- 239000000126 substance Substances 0.000 claims description 7
- HOKIDJSKDBPKTQ-GLXFQSAKSA-N cephalosporin C Chemical group S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-N 0.000 claims description 6
- 239000007858 starting material Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims description 3
- 238000006049 ring expansion reaction Methods 0.000 claims description 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 2
- 239000008363 phosphate buffer Substances 0.000 abstract description 10
- 230000015572 biosynthetic process Effects 0.000 abstract description 9
- 238000003786 synthesis reaction Methods 0.000 abstract description 8
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 abstract description 6
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract description 4
- NVIAYEIXYQCDAN-CLZZGJSISA-N 7beta-aminodeacetoxycephalosporanic acid Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)[C@@H](N)[C@@H]12 NVIAYEIXYQCDAN-CLZZGJSISA-N 0.000 abstract description 4
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 abstract description 4
- 229940106164 cephalexin Drugs 0.000 abstract description 4
- 239000003795 chemical substances by application Substances 0.000 abstract description 4
- 108090000790 Enzymes Proteins 0.000 abstract description 3
- 102000004190 Enzymes Human genes 0.000 abstract description 3
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 abstract description 3
- IKWLIQXIPRUIDU-ZCFIWIBFSA-N (6r)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound OC(=O)C1=CCS[C@@H]2CC(=O)N12 IKWLIQXIPRUIDU-ZCFIWIBFSA-N 0.000 abstract description 2
- FUBBGQLTSCSAON-PBFPGSCMSA-N cefaloglycin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)C)C(O)=O)=CC=CC=C1 FUBBGQLTSCSAON-PBFPGSCMSA-N 0.000 abstract description 2
- 229950004030 cefaloglycin Drugs 0.000 abstract description 2
- 241000534944 Thia Species 0.000 abstract 3
- NVIAYEIXYQCDAN-UHFFFAOYSA-N 7-amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)C(N)C12 NVIAYEIXYQCDAN-UHFFFAOYSA-N 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- ZGUNAGUHMKGQNY-SSDOTTSWSA-N D-alpha-phenylglycine Chemical compound OC(=O)[C@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-SSDOTTSWSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000007071 enzymatic hydrolysis Effects 0.000 abstract 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 abstract 1
- 125000004494 ethyl ester group Chemical group 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000002028 Biomass Substances 0.000 description 7
- 239000000284 extract Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000002255 enzymatic effect Effects 0.000 description 5
- AJHZGVMKIXHMNP-UHFFFAOYSA-N methyl 2-anilinoacetate;hydrochloride Chemical compound Cl.COC(=O)CNC1=CC=CC=C1 AJHZGVMKIXHMNP-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 229940023064 escherichia coli Drugs 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000003301 hydrolyzing effect Effects 0.000 description 3
- YGBFLZPYDUKSPT-MRVPVSSYSA-N cephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)C[C@H]21 YGBFLZPYDUKSPT-MRVPVSSYSA-N 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 108020004256 Beta-lactamase Proteins 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- -1 D-alpha-aminophenylacetamido Chemical group 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- CVWJDUUVFSVART-SECBINFHSA-N ethyl (2r)-2-amino-2-(4-hydroxyphenyl)acetate Chemical compound CCOC(=O)[C@H](N)C1=CC=C(O)C=C1 CVWJDUUVFSVART-SECBINFHSA-N 0.000 description 1
- CVWJDUUVFSVART-UHFFFAOYSA-N ethyl 2-amino-2-(4-hydroxyphenyl)acetate Chemical compound CCOC(=O)C(N)C1=CC=C(O)C=C1 CVWJDUUVFSVART-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 125000000350 glycoloyl group Chemical group O=C([*])C([H])([H])O[H] 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 1
- DTHMTBUWTGVEFG-DDWIOCJRSA-N methyl (2r)-2-amino-2-phenylacetate;hydrochloride Chemical compound Cl.COC(=O)[C@H](N)C1=CC=CC=C1 DTHMTBUWTGVEFG-DDWIOCJRSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229960003424 phenylacetic acid Drugs 0.000 description 1
- 239000003279 phenylacetic acid Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P35/00—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
- C12P35/04—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin by acylation of the substituent in the 7 position
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P35/00—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
- C12P35/02—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin by desacylation of the substituent in the 7 position
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT5448473 | 1973-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS209853B2 true CS209853B2 (en) | 1981-12-31 |
Family
ID=11287332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS748821A CS209853B2 (en) | 1973-12-20 | 1974-12-20 | Method of making the semisynthetic cephalosporine |
Country Status (18)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2105988B1 (es) * | 1996-03-15 | 1998-07-01 | Antibioticos Sa | Procedimiento para purificar 7-sustituido-amino-desacetoxi-cefalosporinas mediante el empleo de membranas de filtracion. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5310156B2 (enrdf_load_stackoverflow) * | 1972-10-21 | 1978-04-11 | ||
| JPS52118A (en) * | 1975-06-23 | 1977-01-05 | Sony Corp | Still picture reproducing device |
-
1974
- 1974-11-28 IL IL46150A patent/IL46150A/xx unknown
- 1974-12-05 AU AU76089/74A patent/AU7608974A/en not_active Expired
- 1974-12-11 ZA ZA00747895A patent/ZA747895B/xx unknown
- 1974-12-12 FR FR7440980A patent/FR2255380B1/fr not_active Expired
- 1974-12-16 GB GB54336/74A patent/GB1480850A/en not_active Expired
- 1974-12-16 BE BE151538A patent/BE823392A/xx not_active IP Right Cessation
- 1974-12-17 YU YU03356/74A patent/YU335674A/xx unknown
- 1974-12-17 LU LU71506A patent/LU71506A1/xx unknown
- 1974-12-18 DD DD183150A patent/DD116833A5/xx unknown
- 1974-12-18 DK DK660374A patent/DK660374A/da not_active Application Discontinuation
- 1974-12-18 NL NL7416549A patent/NL7416549A/xx active Search and Examination
- 1974-12-19 NO NO744590A patent/NO744590L/no unknown
- 1974-12-19 HU HU74SA00002731A patent/HU172077B/hu unknown
- 1974-12-19 CA CA216,466A patent/CA1018091A/en not_active Expired
- 1974-12-19 SE SE7416077A patent/SE7416077L/xx unknown
- 1974-12-20 DE DE19742460607 patent/DE2460607A1/de active Pending
- 1974-12-20 CS CS748821A patent/CS209853B2/cs unknown
- 1974-12-20 JP JP49145850A patent/JPS5095486A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| YU335674A (en) | 1982-05-31 |
| SE7416077L (enrdf_load_stackoverflow) | 1975-06-23 |
| FR2255380A1 (enrdf_load_stackoverflow) | 1975-07-18 |
| LU71506A1 (enrdf_load_stackoverflow) | 1975-06-17 |
| NO744590L (enrdf_load_stackoverflow) | 1975-07-14 |
| BE823392A (fr) | 1975-04-16 |
| IL46150A0 (en) | 1975-02-10 |
| ZA747895B (en) | 1976-01-28 |
| GB1480850A (en) | 1977-07-27 |
| IL46150A (en) | 1979-07-25 |
| DE2460607A1 (de) | 1975-06-26 |
| AU7608974A (en) | 1976-06-10 |
| JPS5095486A (enrdf_load_stackoverflow) | 1975-07-29 |
| DD116833A5 (enrdf_load_stackoverflow) | 1975-12-12 |
| CA1018091A (en) | 1977-09-27 |
| DK660374A (enrdf_load_stackoverflow) | 1975-08-25 |
| FR2255380B1 (enrdf_load_stackoverflow) | 1977-11-10 |
| NL7416549A (nl) | 1975-06-24 |
| HU172077B (hu) | 1978-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2208644C2 (ru) | Способ получения n-деацилированного цефалоспорина | |
| CA2086250C (en) | Process for preparation of beta-lactams | |
| US3945888A (en) | Method for the production of cephalosporins | |
| Vandamme | Peptide antibiotic production through immobilized biocatalyst technology | |
| US4774179A (en) | Process for preparing a 7-aminocephalosporanic acid compound | |
| JPH022396A (ja) | セファロスポリンｃ及び類似体の一段階酵素反応による７‐アミノセファロスポラン酸及びその類似体への変換 | |
| US3880713A (en) | Cephalosporin compounds | |
| US4981789A (en) | One-step enzymatic conversion of cephalosporin C and derivatives to 7-aminocephalosporanic acid and derivatives | |
| US3862004A (en) | Method for production of cephalosporins | |
| EP0915988B1 (en) | Process for the fermentative production of deacylated cephalosporins | |
| US5922907A (en) | Precursors of β-lactam antibacterials having soluble side chain esters | |
| CS209853B2 (en) | Method of making the semisynthetic cephalosporine | |
| EP0638649B1 (en) | New use of alcaligenes faecalis penicillin G acylase | |
| US3976546A (en) | Cephalosporins | |
| CA2168923C (en) | Process for the enzymatic synthesis of .beta.-lactam antibiotics in the presence of an enzyme inhibitor | |
| WO2004020652A2 (en) | An enzymatic process for preparing beta-lactams | |
| CA1069120A (en) | Process for preparing 7-aminocephalosporanic acid derivatives | |
| US20030044884A1 (en) | Synthesis of beta-lactam antibacterials using soluble side chain esters and enzyme acylase | |
| WO2002020819A2 (en) | AN ENZYMATIC PROCESS FOR PREPARING β-LACTAM COMPOUNDS | |
| EP2614066A1 (en) | Process for the production of cephalosporins | |
| US3872088A (en) | Method for the production of d(-)-{60 -aminobenzylpenicillin directly from natural penicillins | |
| CH621575A5 (en) | Process for the enzymatic hydrolysis of cephalosporins | |
| WO1998056945A1 (en) | PROCESS FOR ENZYMATICALLY PREPARING A β-LACTAM ANTIBIOTIC AND THIS ANTIBIOTIC | |
| JPS622798B2 (enrdf_load_stackoverflow) | ||
| JPH01104194A (ja) | Ｄ−（−）−酒石酸の製造法 |